4.6 Article

Clinical and neuropathological features of ALS/FTD with TIA1 mutations

期刊

出版社

BIOMED CENTRAL LTD
DOI: 10.1186/s40478-017-0493-x

关键词

Amyotrophic lateral sclerosis; Frontotemporal dementia; Frontotemporal lobar degeneration; T-cell restricted intracellular antigen-1; TDP-43

资金

  1. Canadian Institutes of Health Research [74580]
  2. Canadian Consortium on Neurodegeneration in Aging [137794]
  3. ALS Canada-Brain Canada Hudson Grant
  4. NIH/NINDS grant [R35 NS097261, P01 NS084974]
  5. NIA [P30 AG13854]

向作者/读者索取更多资源

Mutations in the stress granule protein T-cell restricted intracellular antigen 1 (TIA1) were recently shown to cause amyotrophic lateral sclerosis (ALS) with or without frontotemporal dementia (FTD). Here, we provide detailed clinical and neuropathological descriptions of nine cases with TIA1 mutations, together with comparisons to sporadic ALS (sALS) and ALS due to repeat expansions in C9orf72 (C9orf72+). All nine patients with confirmed mutations in TIA1 were female. The clinical phenotype was heterogeneous with a range in the age at onset from late twenties to the eighth decade (mean = 60 years) and disease duration from one to 6 years (mean = 3 years). Initial presentation was either focal weakness or language impairment. All affected individuals received a final diagnosis of ALS with or without FTD. No psychosis or parkinsonism was described. Neuropathological examination on five patients found typical features of ALS and frontotemporal lobar degeneration (FTLD-TDP, type B) with anatomically widespread TDP-43 proteinopathy. In contrast to C9orf72+ cases, caudate atrophy and hippocampal sclerosis were not prominent. Detailed evaluation of the pyramidal motor system found a similar degree of neurodegeneration and TDP-43 pathology as in sALS and C9orf72+ cases; however, cases with TIA1 mutations had increased numbers of lower motor neurons containing round eosinophilic and Lewy body-like inclusions on HE stain and round compact cytoplasmic inclusions with TDP-43 immunohistochemistry. Immunohistochemistry and immunofluorescence failed to demonstrate any labeling of inclusions with antibodies against TIA1. In summary, our TIA1 mutation carriers developed ALS with or without FTD, with a wide range in age at onset, but without other neurological or psychiatric features. The neuropathology was characterized by widespread TDP-43 pathology, but a more restricted pattern of neurodegeneration than C9orf72+ cases. Increased numbers of round eosinophilic and Lewy-body like inclusions in lower motor neurons may be a distinctive feature of ALS caused by TIA1 mutations.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Clinical Neurology

Genetic screening of a large series of North American sporadic and familial frontotemporal dementia cases

Eliana Marisa Ramos, Deepika Reddy Dokuru, Victoria Van Berlo, Kevin Wojta, Qing Wang, Alden Y. Huang, Sandeep Deverasetty, Yue Qin, Marka van Blitterswijk, Jazmyne Jackson, Brian Appleby, Yvette Bordelon, Patrick Brannelly, Danielle E. Brushaber, Bradford Dickerson, Susan Dickinson, Kimiko Domoto-Reilly, Kelley Faber, Julie Fields, Jamie Fong, Tatiana Foroud, Leah K. Forsberg, Ralitza Gavrilova, Nupur Ghoshal, Jill Goldman, Jonathan Graff-Radford, Neill Graff-Radford, Ian Grant, Murray Grossman, Hilary W. Heuer, Ging-Yuek R. Hsiung, Edward Huey, David Irwin, Kejal Kantarci, Anna Karydas, Daniel Kaufer, Diana Kerwin, David Knopman, John Kornak, Joel H. Kramer, Walter Kremers, Walter Kukull, Irene Litvan, Peter Ljubenkov, Codrin Lungu, Ian Mackenzie, Mario F. Mendez, Bruce L. Miller, Chiadi Onyike, Alexander Pantelyat, Rodney Pearlman, Len Petrucelli, Madeline Potter, Katherine P. Rankin, Katya Rascovsky, Erik D. Roberson, Emily Rogalski, Leslie Shaw, Jeremy Syrjanen, Maria Carmela Tartaglia, Nadine Tatton, Joanne Taylor, Arthur Toga, John Q. Trojanowski, Sandra Weintraub, Bonnie Wong, Zbigniew Wszolek, Rosa Rademakers, Brad F. Boeve, Howard J. Rosen, Adam L. Boxer, Giovanni Coppola

ALZHEIMERS & DEMENTIA (2020)

Article Clinical Neurology

Utility of the global CDR® plus NACC FTLD rating and development of scoring rules: Data from the ARTFL/LEFFTDS Consortium

Toji Miyagawa, Danielle Brushaber, Jeremy Syrjanen, Walter Kremers, Julie Fields, Leah K. Forsberg, Hilary W. Heuer, David Knopman, John Kornak, Adam Boxer, Howard J. Rosen, Bradley F. Boeve, Brian Appleby, Yvette Bordelon, Jessica Bove, Patrick Brannelly, Christina Caso, Giovanni Coppola, Reilly Dever, Christina Dheel, Bradford Dickerson, Susan Dickinson, Sophia Dominguez, Kimiko Domoto-Reilly, Kelley Faber, Jessica Ferrell, Ann Fishman, Jamie Fong, Tatiana Foroud, Ralitza Gavrilova, Debra Gearhart, Behnaz Ghazanfari, Nupur Ghoshal, Jill S. Goldman, Jonathan Graff-Radford, Neill Graff-Radford, Ian Grant, Murray Grossman, Dana Haley, Robin Hsiung, Edward Huey, David Irwin, David Jones, Lynne Jones, Kejal Kantarci, Anna Karydas, Daniel Kaufer, Diana Kerwin, Ruth Kraft, Joel Kramer, Walter Kukull, Irene Litvan, Diane Lucente, Codrin Lungu, Ian Mackenzie, Miranda Maldonado, Masood Manoochehri, Scott McGinnis, Emily McKinley, Mario F. Mendez, Bruce Miller, Namita Multani, Chiadi Onyike, Jaya Padmanabhan, Alexander Pantelyat, Rodney Pearlman, Leonard Petrucelli, Madeline Potter, Rosa Rademakers, Eliana M. Ramos, Kate Rankin, Katya Rascovsky, Erik D. Roberson, Emily Rogalski, Pheth Sengdy, Leslie Shaw, Maria C. Tartaglia, Nadine Tatton, Joanne Taylor, Arthur Toga, John Q. Trojanowski, Ping Wang, Sandra Weintraub, Bonnie Wong, Zbigniew Wszolek

ALZHEIMERS & DEMENTIA (2020)

Article Clinical Neurology

White matter atrophy in cerebral amyloid angiopathy

Panagiotis Fotiadis, Yael D. Reijmer, Susanne J. Van Veluw, Sergi Martinez-Ramirez, Fikret Isik Karahanoglu, Elif Gokcal, Kristin M. Schwab, Joshua N. Goldstein, Jonathan Rosand, Anand Viswanathan, Steven M. Greenberg, M. Edip Gurol

NEUROLOGY (2020)

Article Multidisciplinary Sciences

A telescope GWAS analysis strategy, based on SNPs-genes-pathways ensamble and on multivariate algorithms, to characterize late onset Alzheimer's disease

Margherita Squillario, Giulia Abate, Federico Tomasi, Veronica Tozzo, Annalisa Barla, Daniela Uberti

SCIENTIFIC REPORTS (2020)

Article Neurosciences

Gene Expression Imputation Across Multiple Tissue Types Provides Insight Into the Genetic Architecture of Frontotemporal Dementia and Its Clinical Subtypes

Lianne M. Reus, Bogdan Pasaniuc, Danielle Posthuma, Toni Boltz, Yolande A. L. Pijnenburg, Roel A. Ophoff

Summary: Using a transcriptome-wide association study approach, novel candidate genes associated with FTD were identified, with most significant associations observed in the dorsolateral prefrontal cortex. In addition to SEC22B, the 17q21.31 inversion locus also showed significant associations.

BIOLOGICAL PSYCHIATRY (2021)

Article Neurosciences

Exploring the Contribution of Myelin Content in Normal Appearing White Matter to Cognitive Outcomes in Cerebral Small Vessel Disease

Elizabeth Dao, Roger Tam, Ging-Yuek R. Hsiung, Lisanne ten Brinke, Rachel Crockett, Cindy K. Barha, Youngjin Yoo, Walid Al Keridy, Stephanie H. Doherty, Cornelia Laule, Alex L. MacKay, Teresa Liu-Ambrose

Summary: This exploratory study found a significant association between lower myelin water fraction in the NAWM of cSVD patients and impaired processing speed and working memory, highlighting the importance of myelin in cognitive function.

JOURNAL OF ALZHEIMERS DISEASE (2021)

Article Clinical Neurology

Brain volumetric deficits in MAPT mutation carriers: a multisite study

Stephanie A. Chu, Taru M. Flagan, Adam M. Staffaroni, Lize C. Jiskoot, Jersey Deng, Salvatore Spina, Liwen Zhang, Virginia E. Sturm, Jennifer S. Yokoyama, William W. Seeley, Janne M. Papma, Dan H. Geschwind, Howard J. Rosen, Bradley F. Boeve, Adam L. Boxer, Hilary W. Heuer, Leah K. Forsberg, Danielle E. Brushaber, Murray Grossman, Giovanni Coppola, Bradford C. Dickerson, Yvette M. Bordelon, Kelley Faber, Howard H. Feldman, Julie A. Fields, Jamie C. Fong, Tatiana Foroud, Ralitza H. Gavrilova, Nupur Ghoshal, Neill R. Graff-Radford, Ging-Yuek Robin Hsiung, Edward D. Huey, David J. Irwin, Kejal Kantarci, Daniel I. Kaufer, Anna M. Karydas, David S. Knopman, John Kornak, Joel H. Kramer, Walter A. Kukull, Maria I. Lapid, Irene Litvan, Ian R. A. Mackenzie, Mario F. Mendez, Bruce L. Miller, Chiadi U. Onyike, Alexander Y. Pantelyat, Rosa Rademakers, Eliana Marisa Ramos, Erik D. Roberson, Maria Carmela Tartaglia, Nadine A. Tatton, Arthur W. Toga, Ashley Vetor, Sandra Weintraub, Bonnie Wong, Zbigniew K. Wszolek, John C. Van Swieten, Suzee E. Lee

Summary: This study found that a subset of presymptomatic MAPT mutation carriers exhibited low volumes in the mesial temporal lobe, a region commonly atrophied in all symptomatic carriers. With increasing age, a higher percentage of presymptomatic carriers showed low mesial temporal volume, suggesting early neurodegeneration.

ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2021)

Article Biochemistry & Molecular Biology

Four distinct trajectories of tau deposition identified in Alzheimer's disease

Jacob W. Vogel, Alexandra L. Young, Neil P. Oxtoby, Ruben Smith, Rik Ossenkoppele, Olof T. Strandberg, Renaud La Joie, Leon M. Aksman, Michel J. Grothe, Yasser Iturria-Medina, Michael J. Pontecorvo, Michael D. Devous, Gil D. Rabinovici, Daniel C. Alexander, Chul Hyoung Lyoo, Alan C. Evans, Oskar Hansson

Summary: By using an unbiased subtyping algorithm, the study systematically characterized longitudinal tau variability in human Alzheimer's disease, identifying four trajectories of tau deposition with distinct clinical features. The results suggest that variation in tau pathology is common and systematic, potentially necessitating a re-examination of the notion of 'typical AD' and a revisiting of tau pathological staging.

NATURE MEDICINE (2021)

Article Clinical Neurology

Plasma Neurofilament Light for Prediction of Disease Progression in Familial Frontotemporal Lobar Degeneration

Julio C. Rojas, Ping Wang, Adam M. Staffaroni, Carolin Heller, Yann Cobigo, Amy Wolf, Sheng-Yang M. Goh, Peter A. Ljubenkov, Hilary W. Heuer, Jamie C. Fong, Joanne B. Taylor, Eliseo Veras, Linan Song, Andreas Jeromin, David Hanlon, Lili Yu, Arvind Khinikar, Rajeev Sivasankaran, Agnieszka Kieloch, Marie-Anne Valentin, Anna M. Karydas, Laura L. Mitic, Rodney Pearlman, John Kornak, Joel H. Kramer, Bruce L. Miller, Kejal Kantarci, David S. Knopman, Neill Graff-Radford, Leonard Petrucelli, Rosa Rademakers, David J. Irwin, Murray Grossman, Eliana Marisa Ramos, Giovanni Coppola, Mario F. Mendez, Yvette Bordelon, Bradford C. Dickerson, Nupur Ghoshal, Edward D. Huey, Ian R. Mackenzie, Brian S. Appleby, Kimiko Domoto-Reilly, Ging-Yuek R. Hsiung, Arthur W. Toga, Sandra Weintraub, Daniel I. Kaufer, Diana Kerwin, Irene Litvan, Chiadikaobi U. Onyike, Alexander Pantelyat, Erik D. Roberson, Maria C. Tartaglia, Tatiana Foroud, Weiping Chen, Julie Czerkowicz, Danielle L. Graham, John C. van Swieten, Barbara Borroni, Raquel Sanchez-Valle, Fermin Moreno, Robert Laforce, Caroline Graff, Matthis Synofzik, Daniela Galimberti, James B. Rowe, Mario Masellis, Elizabeth Finger, Rik Vandenberghe, Alexandre de Mendonca, Fabrizio Tagliavini, Isabel Santana, Simon Ducharme, Chris R. Butler, Alexander Gerhard, Johannes Levin, Adrian Danek, Markus Otto, Sandro Sorbi, David M. Cash, Rhian S. Convery, Martina Bocchetta, Martha Foiani, Caroline V. Greaves, Georgia Peakman, Lucy Russell, Imogen Swift, Emily Todd, Jonathan D. Rohrer, Bradley F. Boeve, Howard J. Rosen, Adam L. Boxer, ALLFTD Consortium, GENFI Consortium

Summary: Plasma neurofilament light chain (NfL) can identify asymptomatic carriers of FTLD-causing mutations at risk of disease progression, providing potential for selecting participants in prevention clinical trials.

NEUROLOGY (2021)

Article Medicine, Research & Experimental

Reshaping the path of vascular cognitive impairment with resistance training: a study protocol for a randomized controlled trial

Teresa Liu-Ambrose, Elizabeth Dao, Rachel A. Crockett, Cindy K. Barha, Ryan S. Falck, John R. Best, Ging-Yeuk R. Hsiung, Thalia S. Field, Kenneth M. Madden, Walid A. Alkeridy, Narlon C. Boa Sorte Silva, Jennifer C. Davis, Lisanne F. Ten Brinke, Stephanie Doherty, Roger C. Tam

Summary: SIVCI is the most common form of vascular cognitive impairment and can be delayed through exercise; a study will investigate the effect of resistance training on cognitive function and WMH progression in adults with SIVCI, aiming to slow cognitive decline and preserve quality of life.

TRIALS (2021)

Article Behavioral Sciences

Recognition memory and divergent cognitive profiles in prodromal genetic frontotemporal dementia

Megan S. Barker, Masood Manoochehri, Sandra J. Rizer, Brian S. Appleby, Danielle Brushaber, Sheena Dev, Katrina L. Devick, Bradford C. Dickerson, Julie A. Fields, Tatiana M. Foroud, Leah K. Forsberg, Douglas R. Galasko, Nupur Ghoshal, Neill R. Graff-Radford, Murray Grossman, Hilary W. Heuer, Ging-Yuek Hsiung, John Kornak, Irene Litvan, Ian R. Mackenzie, Mario F. Mendez, Belen Pascual, Katherine P. Rankin, Katya Rascovsky, Adam M. Staffaroni, Maria Carmela Tartaglia, Sandra Weintraub, Bonnie Wong, Bradley F. Boeve, Adam L. Boxer, Howard J. Rosen, Jill Goldman, Edward D. Huey, Stephanie Cosentino

Summary: This study aimed to investigate the performance patterns on an abbreviated list learning task in mutation carriers with mild behavioral and/or cognitive symptoms consistent with prodromal bvFTD, with a focus on recognition memory. Results showed that MAPT mutation carriers performed worse in list recall and had difficulty discriminating targets from distractors on the recognition memory task. Identification of the earliest cognitive indicators of bvFTD is of critical importance, and distinct cognitive profiles may be evident in carriers of the three disease causing genes during the prodromal stage.

CORTEX (2021)

Article Clinical Neurology

Shared brain transcriptomic signature in TDP-43 type A FTLD patients with or without GRN mutations

Cyril Pottier, Ligia Mateiu, Matthew C. Baker, Mariely DeJesus-Hernandez, Cristina Teixeira Vicente, NiCole A. Finch, Shulan Tian, Marka van Blitterswijk, Melissa E. Murray, Yingxue Ren, Leonard Petrucelli, Bjorn Oskarsson, Joanna M. Biernacka, Neill R. Graff-Radford, Bradley F. Boeve, Ronald C. Petersen, Keith A. Josephs, Yan W. Asmann, Dennis W. Dickson, Rosa Rademakers

Summary: By comparing gene expression, the researchers found that patients with GRN mutations and those with unknown mutations have similar transcriptional profiles, involving several potentially druggable pathways. These findings reveal novel disease mechanisms in FTLD and strongly suggest that GRN mutations extend beyond GRN and contribute to genetically unexplained forms of FTLD.
Review Clinical Neurology

A Systematic Review of the Genetics and Pathology of Psychosis in Frontotemporal Dementia

Atri Chatterjee, Veronica Hirsch-Reinshagen, Imogene Scott, Neil Cashman, Ging-Yuek Robin Hsiung

Summary: This study conducted a systematic review and found that the frequency of psychosis in FTD patients was 24.2%. Among the genetic mutation carriers, C9orf72 mutation carriers had the highest frequency of psychosis (31.4%), while GRN and MAPT mutation carriers had lower frequencies of psychosis. Among the pathological subtypes, patients with FUS pathology, TDP-43 pathology, and tau pathology had a prevalence of psychosis at 30%, 25.3%, and 16.4% respectively.

CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES (2023)

Article Clinical Neurology

Clinico-pathological comparison of patients with autopsy-confirmed Alzheimer's disease, dementia with Lewy bodies, and mixed pathology

Atri Chatterjee, Veronica Hirsch-Reinshagen, Syed Ali Moussavi, Blake Ducharme, Ian R. Mackenzie, Ging-Yuek Robin Hsiung

Summary: Patients with both ADNC and LBP have a higher prevalence of DLB symptoms compared to those with pure ADNC, and autonomic dysfunction can serve as a marker for the presence of LBP.

ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING (2021)

Article Clinical Neurology

Plasma Neurofilament Light for Prediction of Disease Progression in Familial Frontotemporal Lobar Degeneration

Julio C. Rojas, Ping Wang, Adam M. Staffaroni, Carolin Heller, Yann Cobigo, Amy Wolf, Sheng-Yang M. Goh, Peter A. Ljubenkov, Hilary W. Heuer, Jamie C. Fong, Joanne B. Taylor, Eliseo Veras, Linan Song, Andreas Jeromin, David Hanlon, Lili Yu, Arvind Khinikar, Rajeev Sivasankaran, Agnieszka Kieloch, Marie-Anne Valentin, Anna M. Karydas, Laura L. Mitic, Rodney Pearlman, John Kornak, Joel H. Kramer, Bruce L. Miller, Kejal Kantarci, David S. Knopman, Neill Graff-Radford, Leonard Petrucelli, Rosa Rademakers, David J. Irwin, Murray Grossman, Eliana Marisa Ramos, Giovanni Coppola, Mario F. Mendez, Yvette Bordelon, Bradford C. Dickerson, Nupur Ghoshal, Edward D. Huey, Ian R. Mackenzie, Brian S. Appleby, Kimiko Domoto-Reilly, Ging-Yuek R. Hsiung, Arthur W. Toga, Sandra Weintraub, Daniel I. Kaufer, Diana Kerwin, Irene Litvan, Chiadikaobi U. Onyike, Alexander Pantelyat, Erik D. Roberson, Maria C. Tartaglia, Tatiana Foroud, Weiping Chen, Julie Czerkowicz, Danielle L. Graham, John C. van Swieten, Barbara Borroni, Raquel Sanchez-Valle, Fermin Moreno, Robert Laforce, Caroline Graff, Matthis Synofzik, Daniela Galimberti, James B. Rowe, Mario Masellis, Elizabeth Finger, Rik Vandenberghe, Alexandre de Mendonca, Fabrizio Tagliavini, Isabel Santana, Simon Ducharme, Chris R. Butler, Alexander Gerhard, Johannes Levin, Adrian Danek, Markus Otto, Sandro Sorbi, David M. Cash, Rhian S. Convery, Martina Bocchetta, Martha Foiani, Caroline V. Greaves, Georgia Peakman, Lucy Russell, Imogen Swift, Emily Todd, Jonathan D. Rohrer, Bradley F. Boeve, Howard J. Rosen, Adam L. Boxer

Summary: Plasma neurofilament light chain (NfL) can identify asymptomatic carriers of FTLD-causing mutations at risk of disease progression. Higher baseline NfL levels are associated with worse clinical progression, neuropsychological function, and brain atrophy.

NEUROLOGY (2021)

暂无数据